Abstract:Background: We report elsewhere in this meeting (N. Kapoor et al. abstract) that Tbx18, an embryonic T-box transcription factor, reprograms cultured cardiomyocytes to induced sinoatrial node (SAN) pacemaker cells. Here we sought to test the fidelity of reprogramming by expressing Tbx18 in adult ventricle and comparing the properties of Tbx18-transduced ventricular myocytes (Tbx-VMs) with those of GFP-transduced ventricular myocytes (as controls; control-VMs) and native SAN cells. Methods: Adenoviruses co-expressing Tbx18 and GFP, or GFP alone, were directly injected in the apex of the guinea pig heart (4×107cfu/heart). Five days later, the heart was harvested and cardiomyocytes were isolated from the site of virus injection. Results: Native SAN cells are smaller and leaner than nontransduced VMs: length-to-width (LtW) ratios equal 14.7±1.5 (n=28) and 7.6±0.7 (n=9), respectively. Freshly-isolated control-VMs maintained their native shape (LtW=7.4±0.9, n=4); in contrast, Tbx-VMs were leaner (LtW=16.0±1.0, n=12) than control-VMs and were often spindle-shaped, reproducing the morphological hallmark of SAN cells. Control-VMs had stable resting potentials at −76mV, with action potentials (APs) elicited only upon electrical stimulation. In contrast, spindle-shaped Tbx-VMs demonstrated diastolic depolarization (maximal diastolic potential=-59mV) and fired spontaneous APs at 26bpm.The whole-cell capacitance (a measure of cell size) of Tbx-VMs was smaller than that of control-VMs (40.8±3.6 vs. 119±16pF, respectively), but similar to that of native SAN cells (48.3±7.0pF). The electrophysiological and morphological features of Tbx-VMs generally resembled those of native SAN cells. Conclusion: Somatic gene transfer of Tbx18 in the ventricle in vivo yielded induced SAN (iSAN) cells which faithfully recapitulate the key phenotypic properties of genuine SAN cells. The in situ reprogramming was effective and swift (as little as five days), offering a novel approach to creating a biological pacemaker as an alternative to electronic devices.

Biomaterial-induced conversion of quiescent cardiomyocytes into pacemaker cells in rats

Engineering Human Ventricular Heart Muscles Based on a Highly Efficient System for Purification of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes

Biological pacemaker created by fetal cardiomyocyte transplantation

Transplanted Neonatal Cardiomyocytes As A Potential Biological Pacemaker in Pigs with Complete Atrioventricular Block

Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker

Induced Pacemaker Cells Created By In Vivo Somatic Reprogramming: Phenotypic Comparison With Native Sinoatrial Node Cells

Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18

Biological Approaches to Generating Cardiac Biopacemaker for Bradycardia.

A New Combination of Transcription Factors Increases the Harvesting Efficiency of Pacemaker‑like Cells.

An Engineering-Optimized Cardiac Pacemaker by Manipulating Na+/Ca2+ Exchange Current and Na+/K+ Pumping Current

Cadherin-5 Facilitated the Differentiation of Human Induced Pluripotent Stem Cells into Sinoatrial Node-Like Pacemaker Cells by Regulating Β-Catenin

Insulin Gene Enhancer Binding Protein 1 Induces Adipose Tissue‑derived Stem Cells to Differentiate into Pacemaker‑like Cells

Multimaterial Printing of Serpentine Microarchitectures with Synergistic Mechanical/Piezoelectric Stimulation for Enhanced Cardiac‐Specific Functional Regeneration

Engineering a conduction-consistent cardiac patch with rGO/PLCL electrospun nanofibrous membranes and human iPSC-derived cardiomyocytes

Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias

5-Azacytidine-Induced Cardiomyocyte Differentiation of Very Small Embryonic-Like Stem Cells

Genetically-engineered mesenchymal stem cells transfected with human HCN1 gene to create cardiac pacemaker cells.

iPSC-Derived Biological Pacemaker—From Bench to Bedside

A self-powered intracardiac pacemaker in swine model

Genetically engineered cardiac pacemaker: stem cells transfected with HCN2 gene and myocytes - a model

[Transfecting Rat Heart with Human Pacemaker Gene in Vivo to Create a Biological Pacemaker].